MXPA06014266A - Agentes de diagnostico para formacion de imagenes por emision de positrones utilizando xantenos halogenados radioetiquetados y metodos para la formacion de imagenes por emision de positrones con agentes de diagnostico de xantenos halogenados radioeti - Google Patents

Agentes de diagnostico para formacion de imagenes por emision de positrones utilizando xantenos halogenados radioetiquetados y metodos para la formacion de imagenes por emision de positrones con agentes de diagnostico de xantenos halogenados radioeti

Info

Publication number
MXPA06014266A
MXPA06014266A MXPA06014266A MXPA06014266A MXPA06014266A MX PA06014266 A MXPA06014266 A MX PA06014266A MX PA06014266 A MXPA06014266 A MX PA06014266A MX PA06014266 A MXPA06014266 A MX PA06014266A MX PA06014266 A MXPA06014266 A MX PA06014266A
Authority
MX
Mexico
Prior art keywords
positron emission
diagnostic agents
emission imaging
radiolabeled
radiolabeled halogenated
Prior art date
Application number
MXPA06014266A
Other languages
English (en)
Inventor
Eric A Wachter
Craig H Dees
Timothy C Scott
Original Assignee
Xantech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/050,512 external-priority patent/US7338652B2/en
Priority claimed from US11/049,797 external-priority patent/US7427389B2/en
Application filed by Xantech Pharmaceuticals Inc filed Critical Xantech Pharmaceuticals Inc
Publication of MXPA06014266A publication Critical patent/MXPA06014266A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K51/0421—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Abstract

Se describen nuevos agentes de diagnostico para tomografia por emision de positron (PET) y metodos de uso para tales agentes para formar imagenes de tejido humano o animal, en donde el componente activo primario de tales agentes es un xanteno halogenado radioetiquetado o derivado de xanteno halogenado radioetiquetado. Preferentemente, el xanteno halogenado radioetiquetado es Rose Bengal radioetiquetado o un derivado funcional de Rose Bengal.
MXPA06014266A 2004-06-10 2005-05-13 Agentes de diagnostico para formacion de imagenes por emision de positrones utilizando xantenos halogenados radioetiquetados y metodos para la formacion de imagenes por emision de positrones con agentes de diagnostico de xantenos halogenados radioeti MXPA06014266A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57862204P 2004-06-10 2004-06-10
US11/050,512 US7338652B2 (en) 2004-06-10 2005-02-03 Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents
US11/049,797 US7427389B2 (en) 2004-06-10 2005-02-03 Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes
PCT/US2005/016836 WO2006001925A1 (en) 2004-06-10 2005-05-13 Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes and methods for positron emission imaging with radiolabeled halogenated xanthene diagnostic agents

Publications (1)

Publication Number Publication Date
MXPA06014266A true MXPA06014266A (es) 2007-05-23

Family

ID=35782109

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06014266A MXPA06014266A (es) 2004-06-10 2005-05-13 Agentes de diagnostico para formacion de imagenes por emision de positrones utilizando xantenos halogenados radioetiquetados y metodos para la formacion de imagenes por emision de positrones con agentes de diagnostico de xantenos halogenados radioeti

Country Status (6)

Country Link
EP (1) EP1753467B1 (es)
JP (1) JP2008502717A (es)
CA (1) CA2570687C (es)
ES (1) ES2398962T3 (es)
MX (1) MXPA06014266A (es)
WO (1) WO2006001925A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0613287D0 (en) * 2006-07-05 2006-08-16 Ge Healthcare Ltd Dye imaging agents
ES2548575T3 (es) * 2009-09-18 2015-10-19 Provectus Pharmatech, Inc. Procedimiento para la síntesis de 4,5,6,7-tetracloro-3',6'-dihidroxi-2',4',5',7'-tetrayodo-3H-espiro[isobenzofuran-1,9'-xanten]-3-ona (Rosa de Bengala) y xantenos relacionados
GB201019303D0 (en) 2010-11-15 2010-12-29 Strom Hans E P Agents and methods for visualising analytes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB846674A (en) * 1958-04-29 1960-08-31 Univ Kansas Res Foundation Xanthene compounds and dyestuffs and means of producing the same
US4256727A (en) * 1978-09-18 1981-03-17 The University Of Kentucky Research Foundation Synthesis and use of diagnostic radio-pharmaceuticals comprising radioactive isotopes of bromine with dyes
US7390668B2 (en) * 1996-10-30 2008-06-24 Provectus Pharmatech, Inc. Intracorporeal medicaments for photodynamic treatment of disease
US6331286B1 (en) * 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
JP2000344684A (ja) * 1999-03-26 2000-12-12 Bf Kenkyusho:Kk ピロニンｂ類似化合物によるアミロイドが蓄積する疾患の画像診断プローブおよびそれを含む画像診断用組成物

Also Published As

Publication number Publication date
CA2570687A1 (en) 2006-01-05
EP1753467A1 (en) 2007-02-21
CA2570687C (en) 2013-07-09
EP1753467A4 (en) 2008-09-17
WO2006001925A1 (en) 2006-01-05
ES2398962T3 (es) 2013-03-22
JP2008502717A (ja) 2008-01-31
EP1753467B1 (en) 2013-01-09

Similar Documents

Publication Publication Date Title
EP1627410A4 (en) COMPUTERIZED TOMOGRAPHY SYSTEM FOR IMAGING PEOPLE AND CLINES
AU2003295644A8 (en) Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
HK1114419A1 (en) Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
WO2003105757A3 (en) METHODS AND COMPOSITIONS FOR MEDIA-DEPENDENT BINDING OF A TARGET AGENT TO A TARGET
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
PL1750596T3 (pl) Element łączący do wprowadzania do środka struktury kostnej ciała człowieka lub zwierzęcia i związany z nim system lokalizujący
DK1131096T3 (da) Anti-CD20-antistofbehandling af patienter, der modtager knoglemarvs- eller periferisk blodstamcelletransplantationer
AU2003205077A1 (en) Imaging agents and methods of imaging naaladase of psma
DE60015778D1 (de) Implantat
IL166571A0 (en) Medical treatment system by substituting native biological regulatory function: cardiac pacing system blood pressure regulating system and cardiac disease treatment system based on the medical system
EA200201258A1 (ru) Способ лучевой терапии
ATE453646T1 (de) 3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren
ECSP088203A (es) Dispersiones amorfas sólidas
CY1115407T1 (el) Θοριο-227 για χρηση στην ακτινοθεραπεια ασθενειων των μαλακων ιστων
IL163547A0 (en) Use of the axl receptor for diagnosis and treatment of renal disease
MXPA06014266A (es) Agentes de diagnostico para formacion de imagenes por emision de positrones utilizando xantenos halogenados radioetiquetados y metodos para la formacion de imagenes por emision de positrones con agentes de diagnostico de xantenos halogenados radioeti
AU2003210266A8 (en) Treatment, diagnosis and imaging of disease
TW200744647A (en) Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
DE50310113D1 (de) Sgk und nedd als diagnostische und therapeutische targets
MXPA05005460A (es) Contraste de ultrasonido que usa xantenos halogenados.
AU4418400A (en) Treatment, imaging and diagnosis of disease using an agent which binds alfa5-integrin
BRPI0411169A (pt) preparação injetável ou implantável e seu uso
TW200744645A (en) Contrast agents for myocardium perfusion imaging
WO2004100759A3 (en) Endo 180 receptor for diagnosis and treatment
NO20064232L (no) Alfa.emitterende hydroksyapatittparikler

Legal Events

Date Code Title Description
FG Grant or registration